These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

371 related articles for article (PubMed ID: 9480984)

  • 1. A novel sialic acid binding site on factor H mediates serum resistance of sialylated Neisseria gonorrhoeae.
    Ram S; Sharma AK; Simpson SD; Gulati S; McQuillen DP; Pangburn MK; Rice PA
    J Exp Med; 1998 Mar; 187(5):743-52. PubMed ID: 9480984
    [TBL] [Abstract][Full Text] [Related]  

  • 2. α-2,3-sialyltransferase expression level impacts the kinetics of lipooligosaccharide sialylation, complement resistance, and the ability of Neisseria gonorrhoeae to colonize the murine genital tract.
    Lewis LA; Gulati S; Burrowes E; Zheng B; Ram S; Rice PA
    mBio; 2015 Feb; 6(1):. PubMed ID: 25650401
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complement processing and immunoglobulin binding to Neisseria gonorrhoeae determined in vitro simulates in vivo effects.
    McQuillen DP; Gulati S; Ram S; Turner AK; Jani DB; Heeren TC; Rice PA
    J Infect Dis; 1999 Jan; 179(1):124-35. PubMed ID: 9841831
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Cardenas AJ; Thomas KS; Broden MW; Ferraro NJ; Pires MM; John CM; Jarvis GA; Criss AK
    mBio; 2024 May; 15(5):e0011924. PubMed ID: 38587424
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional comparison of the binding of factor H short consensus repeat 6 (SCR 6) to factor H binding protein from Neisseria meningitidis and the binding of factor H SCR 18 to 20 to Neisseria gonorrhoeae porin.
    Shaughnessy J; Lewis LA; Jarva H; Ram S
    Infect Immun; 2009 May; 77(5):2094-103. PubMed ID: 19273554
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Utilizing CMP-Sialic Acid Analogs to Unravel Neisseria gonorrhoeae Lipooligosaccharide-Mediated Complement Resistance and Design Novel Therapeutics.
    Gulati S; Schoenhofen IC; Whitfield DM; Cox AD; Li J; St Michael F; Vinogradov EV; Stupak J; Zheng B; Ohnishi M; Unemo M; Lewis LA; Taylor RE; Landig CS; Diaz S; Reed GW; Varki A; Rice PA; Ram S
    PLoS Pathog; 2015 Dec; 11(12):e1005290. PubMed ID: 26630657
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human factor H interacts selectively with Neisseria gonorrhoeae and results in species-specific complement evasion.
    Ngampasutadol J; Ram S; Gulati S; Agarwal S; Li C; Visintin A; Monks B; Madico G; Rice PA
    J Immunol; 2008 Mar; 180(5):3426-35. PubMed ID: 18292569
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factor H facilitates adherence of Neisseria gonorrhoeae to complement receptor 3 on eukaryotic cells.
    Agarwal S; Ram S; Ngampasutadol J; Gulati S; Zipfel PF; Rice PA
    J Immunol; 2010 Oct; 185(7):4344-53. PubMed ID: 20826755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of exogenous sialylation of the lipooligosaccharide of Neisseria gonorrhoeae on opsonophagocytosis.
    Kim JJ; Zhou D; Mandrell RE; Griffiss JM
    Infect Immun; 1992 Oct; 60(10):4439-42. PubMed ID: 1398958
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular characterization of the interaction between sialylated Neisseria gonorrhoeae and factor H.
    Shaughnessy J; Ram S; Bhattacharjee A; Pedrosa J; Tran C; Horvath G; Monks B; Visintin A; Jokiranta TS; Rice PA
    J Biol Chem; 2011 Jun; 286(25):22235-42. PubMed ID: 21531728
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced factor H binding to sialylated Gonococci is restricted to the sialylated lacto-N-neotetraose lipooligosaccharide species: implications for serum resistance and evidence for a bifunctional lipooligosaccharide sialyltransferase in Gonococci.
    Gulati S; Cox A; Lewis LA; Michael FS; Li J; Boden R; Ram S; Rice PA
    Infect Immun; 2005 Nov; 73(11):7390-7. PubMed ID: 16239538
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of Gonococcal Neisserial Surface Protein A (NspA) in Serum Resistance and Comparison of Its Factor H Binding Properties with Those of Its Meningococcal Counterpart.
    Lewis LA; Rice PA; Ram S
    Infect Immun; 2019 Feb; 87(2):. PubMed ID: 30510105
    [No Abstract]   [Full Text] [Related]  

  • 13. A Novel Factor H-Fc Chimeric Immunotherapeutic Molecule against Neisseria gonorrhoeae.
    Shaughnessy J; Gulati S; Agarwal S; Unemo M; Ohnishi M; Su XH; Monks BG; Visintin A; Madico G; Lewis LA; Golenbock DT; Reed GW; Rice PA; Ram S
    J Immunol; 2016 Feb; 196(4):1732-40. PubMed ID: 26773149
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of Complement Factor H-Based Immunotherapeutic Molecules in Tobacco Plants Against Multidrug-Resistant
    Shaughnessy J; Tran Y; Zheng B; DeOliveira RB; Gulati S; Song WC; Maclean JM; Wycoff KL; Ram S
    Front Immunol; 2020; 11():583305. PubMed ID: 33193396
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic CMP-Nonulosonates against Multidrug-Resistant
    Gulati S; Schoenhofen IC; Lindhout-Djukic T; Schur MJ; Landig CS; Saha S; Deng L; Lewis LA; Zheng B; Varki A; Ram S
    J Immunol; 2020 Jun; 204(12):3283-3295. PubMed ID: 32434942
    [No Abstract]   [Full Text] [Related]  

  • 16. Factor H and neisserial pathogenesis.
    Welsch JA; Ram S
    Vaccine; 2008 Dec; 26 Suppl 8(Suppl 8):I40-5. PubMed ID: 19388163
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An optimized Factor H-Fc fusion protein against multidrug-resistant
    Shaughnessy J; Chabeda A; Tran Y; Zheng B; Nowak N; Steffens C; DeOliveira RB; Gulati S; Lewis LA; Maclean J; Moss JA; Wycoff KL; Ram S
    Front Immunol; 2022; 13():975676. PubMed ID: 36110842
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Novel Sialylation Site on Neisseria gonorrhoeae Lipooligosaccharide Links Heptose II Lactose Expression with Pathogenicity.
    Ram S; Gulati S; Lewis LA; Chakraborti S; Zheng B; DeOliveira RB; Reed GW; Cox AD; Li J; St Michael F; Stupak J; Su XH; Saha S; Landig CS; Varki A; Rice PA
    Infect Immun; 2018 Aug; 86(8):. PubMed ID: 29844237
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gonococcal lipooligosaccharide sialylation: virulence factor and target for novel immunotherapeutics.
    Ram S; Shaughnessy J; de Oliveira RB; Lewis LA; Gulati S; Rice PA
    Pathog Dis; 2017 Jun; 75(4):. PubMed ID: 28460033
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Species-specificity of Neisseria gonorrhoeae infection: do human complement regulators contribute?
    Ngampasutadol J; Tran C; Gulati S; Blom AM; Jerse EA; Ram S; Rice PA
    Vaccine; 2008 Dec; 26 Suppl 8():I62-6. PubMed ID: 19388167
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.